Albiglutide

Albiglutide is a glucagon-like peptide-1 agonist (GLP-1) biologic drug indicated in the treatment of type 2 diabetes. It is a dipeptidyl peptidase-4-resistant glucagon-like peptide-1 dimer fused to human albumin.

Online Inquiry

Specification Technical Data Related Products Customer reviews and Q&A Useful Tools Publications

CAT#	10-101-158
CAS	782500-75-8
Synonyms/Alias	Naliglutide; Albugon;GSK 716155; Naliglutide; Syncria;Eperzan;Tanzeum;UNII-5E7U48495E
M.F/Formula	C3232H5032N864O979S41
M.W/Mr.	72970.4029
Application	Albiglutide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Areas of Interest	Type 2 diabetes mellitus

CAT#	Product Name	Inquiry
G16011	([13C6]Leu14)-Glucagon (1-29) (human, rat, porcine)	Inquiry
CAD-111	GLP-1(7-36)-Lys(6-FAM) amide (human, bovine, guinea pig, mouse, rat)	Inquiry
G16032	GLP-2 (1-34), Glucagon-Like Peptide-2 (1-34), human	Inquiry
10-101-46	GLP-1 (7-37) Acetate	Inquiry
G05002	Glucagon (19-29), human	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.